{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:18:03Z","timestamp":1785521883006,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Project Unit of Manisa Celal Bayar University","award":["2023\/078"],"award-info":[{"award-number":["2023\/078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13760-026-03021-z","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:55:55Z","timestamp":1772898955000},"page":"1085-1094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Residual immune activation in cidp remission: the contribution of macrophage-derived cytokines and chemokines"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7888-5396","authenticated-orcid":false,"given":"Yagmur","family":"Inalkac Gemici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0627-8914","authenticated-orcid":false,"given":"Melike","family":"Batum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1792-7533","authenticated-orcid":false,"given":"Alkim Deniz","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-1921","authenticated-orcid":false,"given":"Aysegul Seyma","family":"Sar\u0131tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8429-4201","authenticated-orcid":false,"given":"Aleyna","family":"Kirmizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0345-0264","authenticated-orcid":false,"given":"Cevval","family":"Ulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-9824","authenticated-orcid":false,"given":"Aysin Kisabay","family":"Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"9","key":"3021_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","volume":"7","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC (2011) Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol. 7(9):507\u2013517. https:\/\/doi.org\/10.1038\/nrneurol.2011.121. PMID: 21912406","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"3021_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jns.12455","volume":"26","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA et al (2021) European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force\u2014Second revision. J Peripher Nerv Syst. 26(3):242\u2013268. https:\/\/doi.org\/10.1111\/jns.12455. PMID: 34296711","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"3021_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00060.x","volume":"11","author":"RAC Hughes","year":"2006","unstructured":"Hughes RAC, Allen D, Makowska A, Gregson N (2006) Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 11(1):30\u201346. https:\/\/doi.org\/10.1111\/j.1085-9489.2006.00060.x. PMID: 16519779","journal-title":"J Peripher Nerv Syst"},{"key":"3021_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-021-02139-5","volume":"18","author":"KM Hagen","year":"2021","unstructured":"Hagen KM, Ousman SS (2021) The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroinflammation 18:78. https:\/\/doi.org\/10.1186\/s12974-021-02139-5","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3021_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s13311-022-01221-y","volume":"19","author":"LA Querol","year":"2022","unstructured":"Querol LA, Hartung HP, Lewis RA, van Doorn PA, Hammond TR, Atassi N, Alonso-Alonso M, Dalakas MC (2022) The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies. Neurotherapeutics 19(3):864\u2013873. https:\/\/doi.org\/10.1007\/s13311-022-01221-yEpub 2022 Apr 4. PMID: 35378684; PMCID: PMC9294101)","journal-title":"Neurotherapeutics"},{"issue":"1","key":"3021_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/cei\/uxad103","volume":"215","author":"AN Ozdag Acarli","year":"2024","unstructured":"Ozdag Acarli AN, Tuzun E, Sanli E, Koral G, Akbayir E, Cakar A, Sirin NG, Soysal A, Aysal F, Durmus H, Parman Y, Yilmaz V (2024) Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes. Clin Exp Immunol 215(1):65\u201378. https:\/\/doi.org\/10.1093\/cei\/uxad103PMID: 37638717; PMCID: PMC10776240","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"3021_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1529-8027.2009.00231.x","volume":"14","author":"L Sanvito","year":"2009","unstructured":"Sanvito L, Makowska A, Mahdi-Rogers M, McCrone P, Hughes RA (2009) Serum cytokines in chronic inflammatory demyelinating polyradiculoneuropathy: a case\u2013control study. J Peripher Nerv Syst 14(3):208\u2009\u2013\u2009214 https:\/\/doi.org\/10.1111\/j.1529-8027.2009.00231.x. PMID: 19788436","journal-title":"J Peripher Nerv Syst"},{"key":"3021_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2014.12.017","volume":"279","author":"M Beppu","year":"2015","unstructured":"Beppu M, Sawai S, Misawa S, Sogawa K, Mori M, Ishige T et al (2015) Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 279:7\u201310. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.12.017. PMID: 25669993","journal-title":"J Neuroimmunol"},{"issue":"10","key":"3021_CR9","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.biocel.2003.10.019","volume":"36","author":"M von Maurer","year":"2004","unstructured":"Maurer M, von Stebut E (2004) Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36(10):1882\u20131886. https:\/\/doi.org\/10.1016\/j.biocel.2003.10.019. PMID: 15203102","journal-title":"Int J Biochem Cell Biol"},{"key":"3021_CR10","doi-asserted-by":"publisher","first-page":"578238","DOI":"10.1016\/j.jneuroim.2023.578238","volume":"385","author":"R Miyazawa","year":"2023","unstructured":"Miyazawa R, Fujimori J, Atobe Y, Nakashima I (2023) CSF CXCL13 is elevated in patients with CIDP and may reflect higher disease activity. J Neuroimmunol 385:578238. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578238Epub 2023 Nov 2. PMID: 37925900","journal-title":"J Neuroimmunol"},{"issue":"4","key":"3021_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/mus.27820","volume":"68","author":"A Al-Zuhairy","year":"2023","unstructured":"Al-Zuhairy A, Jakobsen J (2023) Outcome in chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis. Muscle Nerve 68(4):388\u2013396. https:\/\/doi.org\/10.1002\/mus.27820. Epub 2023 Apr 11. PMID: 36928889","journal-title":"Muscle Nerve"},{"key":"3021_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jneuroim.2008.06.003","volume":"30","author":"X Yang","year":"2008","unstructured":"Yang X, Jin T, Press R, Quezada HC, Fredrikson S, Zhu J (2008) The expression of TNF-alpha receptors 1 and 2 on peripheral blood mononuclear cells in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 30:129\u2013132","journal-title":"J Neuroimmunol"},{"issue":"2","key":"3021_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1529-8027.2009.00220.x","volume":"14","author":"F Madia","year":"2009","unstructured":"Madia F, Frisullo G, Nociti V, Conte A, Luigetti M, Del Grande A et al (2009) pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 14(2):107\u2013117","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"3021_CR14","doi-asserted-by":"publisher","first-page":"e2114406119","DOI":"10.1073\/pnas.2114406119","volume":"119","author":"Y Wang","year":"2022","unstructured":"Wang Y, Guo L, Yin X, McCarthy EC, Cheng MI, Hoang AT, Chen HC, Patel AY, Allard Trout D, Xu E, Yakobian N, Hugo W, Howard JF Jr, Sheu KM, Hoffmann A, Lechner MG, Su MA (2022) Pathogenic TNF-\u03b1 drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity. Proc Natl Acad Sci U S A 119(4):e2114406119. https:\/\/doi.org\/10.1073\/pnas.2114406119PMID: 35058362; PMCID: PMC8795502","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3021_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","volume":"86","author":"EK Mathey","year":"2015","unstructured":"Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS (2015) Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry 86(9):973\u2013985. https:\/\/doi.org\/10.1136\/jnnp-2014-309697Epub 2015 Feb 12. PMID: 25677463; PMCID: PMC4552934","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3021_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08820139.2017.1405978","volume":"47","author":"S Bonin","year":"2018","unstructured":"Bonin S, Zanotta N, Sartori A, Bratina A, Manganotti P, Trevisan G, Comar M (2018) Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. Immunol Invest 47(2):135\u2013145 Epub 2017 Nov 28. PMID: 29182448","journal-title":"Immunol Invest"},{"issue":"1","key":"3021_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/ijms23010179","volume":"23","author":"E Dziadkowiak","year":"2021","unstructured":"Dziadkowiak E, Waliszewska-Pros\u00f3\u0142 M, Nowakowska-Kotas M, Budrewicz S, Koszewicz Z, Koszewicz M (2021) Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). Int J Mol Sci 23(1):179. https:\/\/doi.org\/10.3390\/ijms23010179PMID: 35008604; PMCID: PMC8745770","journal-title":"Int J Mol Sci"},{"key":"3021_CR18","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/acn3.50931","volume":"6","author":"H Ogata","year":"2019","unstructured":"Ogata H, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M et al (2019) Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.Ann. Clin Transl Neurol 6:2304\u20132316","journal-title":"Clin Transl Neurol"},{"issue":"5","key":"3021_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1212\/wnl.56.5.666","volume":"56","author":"S Misawa","year":"2001","unstructured":"Misawa S, Kuwabara S, Mori M, Kawaguchi N, Yoshiyama Y, Hattori T (2001) Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy. Neurology 56(5):666-669. https:\/\/doi.org\/10.1212\/wnl.56.5.666. PMID: 11245723","journal-title":"Neurology"},{"issue":"3","key":"3021_CR20","doi-asserted-by":"publisher","first-page":"e992","DOI":"10.1212\/NXI.0000000000000992","volume":"8","author":"TRP Taylor","year":"2021","unstructured":"Taylor TRP, Galloway J, Davies R, Hyrich K, Dobson R (2021) Demyelinating Events Following Initiation of Anti-TNF\u03b1 Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis. Neurol Neuroimmunol Neuroinflamm 8(3):e992 PMID: 33863839; PMCID: PMC8105908","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"3021_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M, Jing T, Yao Y, Qiu Z, Wang Z, Acu\u00f1a-Castroviejo D, Yang Y (2023) The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett 28(1):51. https:\/\/doi.org\/10.1186\/s11658-023-00462-9PMID: 37370025; PMCID: PMC10303833","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"3021_CR22","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1007\/s10072-020-04949-7","volume":"42","author":"ZJ Zhou","year":"2021","unstructured":"Zhou ZJ, Xia P (2021) Elevated levels of NLRP3 inflammasome in serum of patients with chronic inflammatory demyelinating polyradiculoneuropathy are associated with disease severity. Neurol Sci 42(8):3383\u20133387. https:\/\/doi.org\/10.1007\/s10072-020-04949-7Epub 2021 Jan 7. PMID: 33409826","journal-title":"Neurol Sci"},{"issue":"8","key":"3021_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4049\/jimmunol.0900173","volume":"183","author":"L Franchi","year":"2009","unstructured":"Franchi L, Eigenbrod T, N\u00fa\u00f1ez G (2009) Cutting edge: TNF-\u03b1 mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183(8):792\u2013796. https:\/\/doi.org\/10.4049\/jimmunol.0900173PMID: 19748989; PMCID: PMC2754237","journal-title":"J Immunol"},{"issue":"3","key":"3021_CR24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim JK, Silwal P, Yoshimori T, Jo EK (2021) An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol 18(3):1141\u20131160. https:\/\/doi.org\/10.1038\/s41423-021-00670-3PMID: 33753912; PMCID: PMC8007353","journal-title":"Cell Mol Immunol"},{"key":"3021_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1034\/j.1600-065X.2000.17715.x","volume":"177","author":"M Maurer","year":"2000","unstructured":"Maurer M, Duschl A, Atkinson W, Rihs S, Kapp A (2000) The role of macrophage inflammatory protein-1\u03b1 (MIP-1\u03b1) in allergic inflammation. Immunol Rev 177:175\u2009\u2013184. https:\/\/doi.org\/10.1034\/j.1600-065X.2000.17715.x. PMID: 11138774)","journal-title":"Immunol Rev"},{"issue":"5","key":"3021_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/jnnp-2017-316696","volume":"89","author":"S Misawa","year":"2018","unstructured":"Misawa S, Kuwabara S, Sato Y, Mori M, Hayakawa S, Sawai S et al (2018) Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy treated with IVIg and subcutaneous immunoglobulin. J Neurol Neurosurg Psychiatry 89(5):554\u2013560. https:\/\/doi.org\/10.1136\/jnnp-2017-316696. PMID: 29440117","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3021_CR27","doi-asserted-by":"publisher","first-page":"6693542","DOI":"10.1155\/2021\/6693542","volume":"2021","author":"K Guo","year":"2021","unstructured":"Guo K, Zhang X (2021) Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis. J Immunol Res 2021:6693542. https:\/\/doi.org\/10.1155\/2021\/6693542PMID: 33816637; PMCID: PMC7990547","journal-title":"J Immunol Res"},{"issue":"2","key":"3021_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/jns.12622","volume":"29","author":"C De Cutell\u00e8","year":"2024","unstructured":"Cutell\u00e8 C, De Lorenzo A, Doneddu PE, Creta MF, Selmi C, Liberatore G et al (2024) Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review. J Peripher Nerv Syst 29(2):124\u2013134. https:\/\/doi.org\/10.1111\/jns.12622. PMID: 38600685","journal-title":"J Peripher Nerv Syst"},{"key":"3021_CR29","doi-asserted-by":"publisher","first-page":"1241199","DOI":"10.3389\/fimmu.2023.1241199","volume":"14","author":"I Kmezi\u0107","year":"2023","unstructured":"Kmezi\u0107 I, Zjali\u0107 M, Petkovi\u0107 F, Jeli\u010di\u0107 I, Stojanovi\u0107 M et al (2023) Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay. Front Immunol 14:1241199. https:\/\/doi.org\/10.3389\/fimmu.2023.1241199. PMID: 37601465","journal-title":"Front Immunol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03021-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03021-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03021-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:08:43Z","timestamp":1785517723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03021-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3021"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03021-z","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained on October 23, 2024, under the reference number 20.478.486\/2657.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}